NEW ORLEANS, July 27, 2022 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC ("KSF") are investigating the proposed sale of TYME Technologies, Inc. (NasdaqCM:TYME) to Syros Pharmaceuticals, Inc. (NasdaqGS:SYRS). Under the terms of the proposed transaction, shareholders of TYME are expected to receive approximately 0.4312 shares of Syros for each share of TYME that they own, subject to adjustment based on the amount of TYME's net cash at closing and the number of TYME shares outstanding at closing. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Read more at prnewswire.comTYME TECHNOLOGIES INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TYME Technologies, Inc. - TYME
PR Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/A%20Palantir%20sign%20displayed%20on%20an%20office%20building%20by%20Poetra_RH%20via%20Shutterstock.jpg)
